News

Personalised care in conservative kidney management (CKM) provides person-centred care for patients who have opted for ...
The single mom is urgently seeking a kidney donor and has turned her car into a mobile plea, listing her blood type and contact info.
Mismatches in an immune cell surface receptor could contribute to higher transplant rejection rates, a new study finds.
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.
The Healthy.io, Geisinger and Boehringer Ingelheim partnership showed a 2.5x increase in test completion rates than standard clinical care.
The heart and kidneys are intricately connected, with the health of one impacting the other. Kidney disease increases the risk of cardiovascular complications, often proving fatal. Early detection and ...
E-Poster No. 1325 About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease.
CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, ...
For the four million people diagnosed with chronic renal failure in Canada -- and millions more abroad -- this scientific advancement could have a major impact on early diagnosis and prevention of ...
Allogene Therapeutics Announces ASCO 2025 Abstract Publication Featuring Oral Presentation of ALLO-316 in Kidney Cancer and ALPHA3 TIP Poster for Cema-Cel ...